WASHINGTON, March 25 (UPI) -- Dermatologists and researchers testified Thursday before a U.S. Food and Drug Administration panel considering indoor tanning restrictions, officials said.
The panel, which advises the FDA, reviewed the classification of tanning beds and voted to bar those under the age of 18 from using indoor tanning beds.
Some of the members of the FDA panel dissented on the ban, but said while they agreed with the sentiment of a ban, they thought it would be unrealistic to implement a ban and suggested strong warnings and parental notification be implemented instead, ABC-TV news reported.
Ultraviolet lamps for tanning are considered class I medical devices but are subject to relatively few FDA regulations.
Skin cancer is the most common cancer in the United States, but is one of the few cancers for which there is a preventive option. Using a tanning bed before the age of 35 increases the risk of the deadliest form of skin cancer, melanoma, by 75 percent, the Melanoma Research Foundation said.